Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Miriam Botto"'
Autor:
Darci R Smith, Sara C Johnston, Ashley Piper, Miriam Botto, Ginger Donnelly, Joshua Shamblin, César G Albariño, Lisa E Hensley, Connie Schmaljohn, Stuart T Nichol, Brian H Bird
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 5, p e0006474 (2018)
Rift Valley fever virus (RVFV) is an important mosquito-borne veterinary and human pathogen that has caused large outbreaks of severe disease throughout Africa and the Arabian Peninsula. Currently, no licensed vaccine or therapeutics exists to treat
Externí odkaz:
https://doaj.org/article/203ffc5bf0474aa19283043192efcc6e
Autor:
Miriam Botto, John H. Connor, Kenny L. Lin, Joshua C. Johnson, Anna N. Honko, Joshua D. Shamblin, Judy Y. Yen, Lisa E. Hensley, Carly Wlazlowski, Kathleen A. Cashman, Nancy A. Twenhafel, Heather L. Esham, Arthur J. Goff, Ginger Donnelly
Publikováno v:
Journal of Virology. 89:9875-9885
Marburg virus (MARV) infection is a lethal hemorrhagic fever for which no licensed vaccines or therapeutics are available. Development of appropriate medical countermeasures requires a thorough understanding of the interaction between the host and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80a95ae212419a9d14a450bb84e6eda
https://doi.org/10.1128/jvi.01147-15
https://doi.org/10.1128/jvi.01147-15
Autor:
Eric M. Mucker, Miriam Botto, Suzanne E. Wollen-Roberts, Timothy D. Minogue, Moinya Coomber, Jean-Paul Gonzalez, Sandra L. Bixler, M. Louise M. Pitt, Anna N. Honko, Arthur J. Goff, Louis A. Altamura, Aileen O’Hearn, James Bangura, Nadia Wauquier, Randal J. Schoepp, Janice Duy, Justine M. Zelko, Joshua C. Johnson, Joshua D. Shamblin
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Ebola virus (EBOV) is a negative-strand RNA virus that replicates in the cytoplasm and causes an often-fatal hemorrhagic fever. EBOV, like other viruses, can reportedly encode its own microRNAs (miRNAs) to subvert host immune defenses. miRNAs are sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec205351bef0d39a7f2ea4a6fc83a3e7
https://pubmed.ncbi.nlm.nih.gov/29691416
https://pubmed.ncbi.nlm.nih.gov/29691416
Autor:
Ginger Donnelly, Brian H. Bird, Darci R. Smith, Sara C. Johnston, Joshua D. Shamblin, Sarah E. McCarthy, Miriam Botto, Bridget Lewis, Ashley E. Keeney, Stuart T. Nichol, César G. Albariño, Lisa E. Hensley
Publikováno v:
Journal of Virology
Rift Valley fever (RVF) virus (RVFV) can cause severe human disease characterized by either acute-onset hepatitis, delayed-onset encephalitis, retinitis and blindness, or a hemorrhagic syndrome. The existing nonhuman primate (NHP) model for RVF utili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b6065f6ca7dd3619287e45880dcac5
https://doi.org/10.1128/jvi.06190-11
https://doi.org/10.1128/jvi.06190-11
Autor:
Ginger Donnelly, Ashley E. Piper, Stuart T. Nichol, Miriam Botto, Lisa E. Hensley, Sara C. Johnston, Connie S. Schmaljohn, Darci R. Smith, Joshua D. Shamblin, César G. Albariño, Brian H. Bird
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 5, p e0006474 (2018)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Rift Valley fever virus (RVFV) is an important mosquito-borne veterinary and human pathogen that has caused large outbreaks of severe disease throughout Africa and the Arabian Peninsula. Currently, no licensed vaccine or therapeutics exists to treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c8a17338e59866d6d0f650aac6530f
https://doi.org/10.1371/journal.pntd.0006474
https://doi.org/10.1371/journal.pntd.0006474
Autor:
Miriam Botto, Suzanne E. Wollen, Jo Lynne Raymond, Kenny L. Lin, Arthur J. Goff, Carly Wlazlowski, Joshua D. Shamblin, Sara C. Johnston, Nancy A. Twenhafel, Eric R. Wilkinson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 9, p e0138843 (2015)
PLoS ONE, Vol 10, Iss 9, p e0138843 (2015)
Marburg virus infection in humans causes a hemorrhagic disease with a high case fatality rate. Countermeasure development requires the use of well-characterized animal models that mimic human disease. To further characterize the cynomolgus macaque mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48ddcdd380b7e2fd392cbc76c903d13
http://europepmc.org/articles/PMC4586374
http://europepmc.org/articles/PMC4586374
Autor:
Joshua C. Johnson, Carly Wlazlowski, Ginger Donnelly, Nancy A. Twenhafel, Arthur J. Goff, Evan C. Ewers, Joshua D. Shamblin, Miriam Botto, Heather L. Esham, Lisa E. Hensley, William D. Pratt
Publikováno v:
Viruses; Volume 8; Issue 4; Pages: 87
Viruses
Viruses
Marburg virus causes severe and often lethal viral disease in humans, and there are currently no Food and Drug Administration (FDA) approved medical countermeasures. The sporadic occurrence of Marburg outbreaks does not allow for evaluation of counte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aec17ffc67a76678479fe8b717cfa5f
https://doi.org/10.3390/v8040087
https://doi.org/10.3390/v8040087